Hugh Solvason
Academic Appointments
- Associate Professor - Med Center Line, Psychiatry & Behavioral Science - Psychopharmacology
Contact Information
-
Clinical Offices
Psychiatry Department 401 Quarry Rd Ste 2138 MC 5723 Stanford, CA 94305 Tel Work (650) 723-8335 Fax (650) 723-8331
Professional Snapshot
Clinical Focus
- Psychiatry
Professional Education
| Doctorate Degree: | University of Alabama School of Medicine, AL |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (2001) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1998) |
| Residency: | SUMC - Graduate Medical Education, CA (1997) |
| Internship: | Stanford University Medical Center, CA (1994) |
Scientific Focus
Clinical Trials
- A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder Recruiting
- Repetitive Transcranial Magnetic Stimulation (rTMS) for treatment resistant bipolar depression No longer recruiting
- Treatment of Schizoaffective Disorder Using Mifepristone Terminated
- A safety and efficacy trial of flibanserin in premenopausal women with HSDD No longer recruiting
Publications
- Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007; (5): 429-37
- Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2007; (6): 614-9
- Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology. 2006; (3): 628-36
- Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006; (3): 275-81
- A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol. 2004; (1): 87-90
Help
